DISC MEDICINE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.61 USD | +1.26% |
|
+3.78% | -40.08% |
| May. 09 | Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 08 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
Chart calendar Disc Medicine, Inc.
dbc.onV0W4OmFewEcWeAdi7-8WPchir4Vdq-1w0cShhG7ko.wy8GdvfPcNtORDXpQ0ezuSjkz3KyY4DchUx9I2kBpQj0OkYJ9e5EokkSFA~0349cc6b24c2d8bf783fd5041f4d09a2
Upcoming events on Disc Medicine, Inc.
Past events on Disc Medicine, Inc.
| 2024-05-20 10:30 am | H.C. Wainwright BioConnect Investor Conference |
| 2024-05-09 08:00 am | Q1 2024 Earnings Release |
| 2024-04-01 08:30 am | AURORA Phase 2 Study Topline Results Call |
| 2024-03-21 08:00 am | Q4 2023 Earnings Release |
| 2024-03-11 10:40 am | Leerink Partners Global Biopharma Conference |
| 2024-01-10 05:15 pm | JPMorgan Healthcare Conference |
| 2023-12-11 09:30 pm | American Society of Hematology Meeting |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract Number: 4564 |
| 2023-12-11 08:30 pm | American Society of Hematology Meeting - Abstract Number: 923 |
| 2023-12-08 | American Society of Hematology Meeting - Abstract Number: 5228 |
| 2023-12-08 | American Society of Hematology Meeting - Abstract Number: 5236 |
| 2023-12-08 | American Society of Hematology Meeting - Abstract Number: 5224 |
| 2023-11-30 02:30 pm | Piper Sandler Healthcare Conference |
| 2023-11-16 04:30 am | Jefferies London Healthcare Conference |
| 2023-11-15 11:30 am | Stifel Healthcare Conference |
| 2023-11-09 08:30 am | Q3 2023 Earnings Release |
| 2023-09-27 02:25 pm | Cantor Global Healthcare Conference |
| 2023-09-13 10:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-13 08:50 am | Morgan Stanley Global Healthcare Conference |
| 2023-09-08 08:45 am | Wells Fargo Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -91,0 -80,8 -12.68% | -132 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -47,5 -69,4 31.58% | -91,1 -83,3 -9.46% | -142 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -46,8 -82,4 43.2% | -76,3 -71,8 -6.24% | -119 |
|
Net income Million USD | Released Forecast Spread | -36,0 | -46,8 -78,6 40.39% | -76,4 -71,4 -7.03% | -119 |
|
EPS USD | Released Forecast Spread | -4,49 | -45,1 -4,68 -862.61% | -3,42 -3,23 -5.99% | -4,72 |
| Announcement Date | 02/09/22 | 31/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -15,0 -15,2 1.19% | -25,1 -14,7 -71.45% | -17,3 -19,3 10.06% | -19,0 -19,0 0.29% | -29,7 -20,3 -46.65% | -31,5 -27,0 -16.68% | -31,3 | -31,7 | -34,9 | -37,8 | -35,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,2 -14,9 24.42% | -22,8 -14,7 -54.36% | -15,9 -18,8 15.52% | -14,1 -17,8 20.99% | -23,5 -19,1 -23.6% | -26,9 -24,4 -10.23% | -29,5 | -29,9 | -33,1 | -37,8 | -35,3 | |
|
Net income Million USD | Released Forecast Spread | -16,2 | -11,2 -14,1 20.19% | -22,8 -14,1 -61.48% | -15,9 -18,8 15.39% | -14,1 -17,4 18.87% | -23,6 -18,5 -27.17% | -26,9 -25,0 -7.99% | -29,3 | -29,8 | -32,9 | -37,8 | -35,3 |
|
EPS USD | Released Forecast Spread | -1,86 | -40,9 -0,81 -4981.99% | -1,20 -0,75 -60% | -0,74 -0,91 18.83% | -0,58 -0,76 23.83% | -0,97 -0,77 -25.97% | -1,09 -1,04 -5.14% | -1,18 | -1,20 | -1,26 | -1,34 | -1,36 |
| Announcement Date | 23/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Disc Medicine, Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IRON Stock
- Calendar Disc Medicine, Inc.
